Evidence map›Paper›PMID 39797137›Full record

ArticleJournal of clinical medicine2024

The Clinical and Economic Burden of Chronic Kidney Disease in Poland: Inside Patient-Level Microsimulation Modelling of CKD.

Anna Masajtis-Zagajewska, Renata Kurek, Katarzyna Modrzyńska, Timothy Coker, Michał Nowicki

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Masajtis-ZagajewskaDepartment of Nephrology, Hypertension, Transplantation and Internal Medicine, Central University Hospital, Medical University of Lodz, 90-419 Lodz, Poland.
Renata KurekMedical Affairs, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceuticals, AstraZeneca Europe and Canada, 31-503 Krakow, Poland.
Katarzyna ModrzyńskaMedical Affairs, Cardiovascular Renal and Metabolism (CVRM), BioPharmaceuticals, AstraZeneca Europe and Canada, 31-503 Krakow, Poland.
Timothy CokerHealthLumen Limited, London EC3N 2PJ, UK.ORCID 0000-0002-2516-0639
Michał NowickiDepartment of Nephrology, Hypertension, Transplantation and Internal Medicine, Central University Hospital, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-0823-5440

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney disease (CKD)economic burdenepidemiological impact

Identifiers

PMID39797137
PMCPMC11721912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.